Durall William Scott 4

What Happened

• Durall William Scott, Chief Commercial Officer of Carlsmed, Inc. (CARL), was granted 44,977 restricted stock units (RSUs) on 2026-01-28. The grant was reported as an award/acquisition at $0.00 per unit (reported acquisition value $0).
• This was an equity compensation award (not an open-market purchase or sale).

Key Details

• Transaction date and price: 2026-01-28, grant recorded at $0.00 per RSU.
• Total units granted: 44,977 RSUs (each unit represents a contingent right to one share).
• Vesting: RSUs vest in three equal annual installments beginning on the first anniversary of the grant date (per footnote F1).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Filing date/timeliness: Form 4 filed 2026-01-30 (two days after the transaction) — appears timely.
• Transaction code: A (award/grant). No 10b5-1 plan, tax-withholding disposition, or sale reported in the excerpt.

Context

• RSU grants are routine executive compensation and represent a future right to receive shares if vesting conditions are met; they are not an immediate cash purchase or sale. Such awards typically reflect employee compensation rather than a direct signal of insider buying or selling.